Victoria Jordan

Vic has worked in market access roles for nearly 15 years, starting her career at a specialist market access consultancy before moving to a pharmaceutical company and then the ABPI. At the ABPI, Vic leads on access related policy strategy and the delivery of a work programme that seeks to ensure new medicines are made available to NHS patients with companies appropriately rewarded for their value. The value and access team’s agenda spans from horizon scanning and system preparedness through to medicines evaluation (HTA) and adoption in the NHS.

Vic takes a collaborative approach to finding solutions for improving patient access to innovative medicines, working with industry, government, system partners, patient groups and academics. Over the last eight years, her work at the ABPI has helped evolve medicines value and access policy in the UK, including the negotiation and implementation of Chapter 3 (access, adoption and outcomes) of the 2019 and 2024 Voluntary Schemes, updates to NICE’s manual for health technology evaluation and the development of the Competition and Markets Authority’s prioritisation statement for combination therapies.

Vic has a Masters in Economic Evaluation for HTA, Health Economics from the University of York and enjoys bringing together advances in medicines evaluation methods and processes with the practicalities of getting new medicines to patients in the NHS.